Adriann Sax

Specialized Health Products International, Inc. develops, manufactures, and markets proprietary disposable medical devices for clinician and patient safety. Its products include LiftLoc, PowerLoc, and MiniLoc Safety Infusion Set, SecureLoc Safety Introducer Needle, SafeStep Huber Needle Set, and Monoject Bone Marrow Biospy Needles. The company was founded in 1993 and is headquartered in Bountiful, UT.

Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada.

Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom.

Part of Lumos Pharma, Inc., BioProtection Systems Corp. is a company that manufactures biological products. The company is based in Ames, IA.

Netsertive, Inc. provides online marketing and advertising services for small and medium businesses. Its solutions include agencies, automotive, franchises, healthcare, and retail. The company was founded by Brendan Morrissey and William Oland Nagel in 2009 and is headquartered in Morrisville, NC.

Galen Management LLC (Galen Management) Is a private equity firm founded in 1990 by John Wilkerson and William Grant. The firm is headquartered in Stamford, Connecticut.

The Florida Bar operates as professional organization of lawyers. The company is headquartered in Tallahassee, FL.

Healthios Capital Markets LLC provides financial advisory services. The private company is based in Northbrook, IL and has subsidiaries in Thailand and Singapore. The company was founded by Fritz Reichenbach.

TheraFuse, Inc. designs and develops non-contact optical flow sensors for use in the commercial, industrial and medical applications. It offers delivery systems for insulin, pain medication, and protein drugs, disposable insulin patches for diabetics; and sprinkler hypodermic needles for sub-Q fluid delivery in drug pens. The company was founded in 2001 and is headquartered in Carlsbad, CA.

Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA.

Greenberg Traurig PA operates as a law firm. It provides legal services. The company was founded by Mel Greenberg, Robert Traurig, and Larry J. Hoffman in 1967 and is headquartered in Miami, FL.

Consensys Imaging Service, Inc. specializes in diagnostic imaging equipment service with a national foot-print. It offers full service contracts, preventive maintenance, time and materials service, remote service support, equipment relocation, and equipment accreditation consulting. The firm serves hospitals, imaging centers, veterinary clinics, original equipment manufacturers, and imaging service providers. The company was founded in 2009 and is headquartered in Cary, IL.

MacuCLEAR, Inc. manufactures pharmaceutical products for vascular eye disorders. The company was founded by George C. Y. Chiou and is headquartered in Richardson, TX.

Part of Regent Technologies, Inc., Regent GLSC Technologies, Inc. is a company that manufactures medical equipment. The company is based in Dallas, TX. David Arthur Nelson has been the CEO of the company since 2007.

Part of Cyclone Power Technologies, Inc., WHE Generation Corp manufactures external combustion, heat-regenerative engines. The company is based in Fairfield, OH. Christopher M. Nelson has been the CEO of the company since 2014.

Part of General Electric Co., Unisyn, Inc. is a company that provides medical imaging services. The company is based in Boulder, CO. Jeffrey M. Soinski has been the CEO of the company since 2009.

Q2Power Corp. provides renewable energy services. Its technology is designed to provide distributed power solution for the underserved, small-scale biogas and waste methane producing sites in the U.S. and globally. Its proprietary engine converts thermal energy (heat) into usable power than its competition. The company is headquartered in Hallandale, OH.

NovaScan, Inc. engages in the development of a technology that electrically images objects. Its technology measures the electrical properties of materials. The firm focuses on breast cancer detection. The company was founded in 2001 by Larry Wells and William Gregory and is headquartered in Chicago, IL.

Part of Bandwidth, Inc., Bandwidth.com CLEC LLC is a company that provides business communications services. The company is based in Raleigh, NC.

ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL.

Earth Property Holdings LLC operates as a investment holding company. The company is headquartered in Atlanta, CA.

Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA.

Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020.